FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD. – Trademark Portfolio
Entity Type: 22
FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DR.LEEQIU. The owner is based in PUTIAN CITY.
ROOM 1205, 2ND FLOOR, BUILDING 3, LIFENG MANSION, NO. 2603 SHENGLI NORTH STREET, GONGCHEN SUBDISTRICT, LICHENG DISTRICT
PUTIAN CITY , CN
Showing of trademarks Trademarks
Trademark Classifications
FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD. have?
FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD. file in?
FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD.'s most well-known trademarks?
FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD.'s registered trademark portfolio includes well-known marks such as DR.LEEQIU. These are among 1 currently registered trademark in the portfolio.
What is FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD.'s trademark registration success rate?
FUJIAN RANSHENG INFORMATION CONSULTING CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.